Cary Street Partners Investment Advisory’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
CB
RRAM
Cary Street Partners Investment Advisory's LH Position: Q2 2026 in Review
Cary Street Partners Investment Advisory reduced its Labcorp (LH) stake by 2.1% in Q2 2026, selling an estimated $3.94K and leaving 684 shares worth $192K. The position accounts for 0.04% of the portfolio, ranked #385.
Cary Street Partners Investment Advisory first reported a position in LH in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.38M in Q4 2021. 560 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Cary Street Partners Investment Advisory held 684 shares of Labcorp worth $192K as of Q2 2026.
- Cary Street Partners Investment Advisory sold 15 Labcorp shares in Q2 2026, an estimated $3.94K.
- Labcorp made up 0.04% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #385 holding.
- Cary Street Partners Investment Advisory first reported a position in Labcorp in Q3 2020 and has held it in 24 quarters since.
- Cary Street Partners Investment Advisory's Labcorp position peaked at $4.38M in Q4 2021.
- 560 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.